Stock listing
NASDAQ:MDVN Medivation Inc Stock
Follow Medivation Inc into a list and get an email when it puts out news.
Last close · NASDAQ:MDVN
$81.44 USD
Close on Sep 27, 2016 · No longer trades
- Lowest – highest close
- $27.32 – $81.44 USDSince Sep 16, 2015 · lowest Feb 8, 2016 · highest Sep 27, 2016
Delisted NASDAQ:MDVN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MDVN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Medivation Inc on 6ix
- Decks
- 6 decks · latest Jul 6, 2016
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (July 2016) | Investor deck | 57 slides | Jul 6, 2016 |
| Merger or Acquisition (June 2016) | Merger or acquisition | 49 slides | Jun 6, 2016 |
| Merger or Acquisition (May 2016) | Merger or acquisition | 45 slides | May 9, 2016 |
| Merger or Acquisition (May 2016) | Merger or acquisition | 41 slides | May 6, 2016 |
| Q1 2016 Earnings Presentation | Earnings | 17 slides | May 6, 2016 |
| JP Morgan Healthcare Conference 2016 | Conference | 42 slides | Jan 11, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dawn Svoronos Other companies: Adverum Biotechnologies Inc (Director · Since at least Dec 9, 2020); Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Global Blood Therapeutics Inc (Director · Dec 19, 2018 – Oct 5, 2022 · Past); Endocyte Inc (Director · May 3, 2018 – Dec 21, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past) | Director · Apr 22, 2013 – Sep 28, 2016 · Past |
| Stephen Michael Kelsey Other companies: Revolution Medicines, Inc. (See Remarks · Since at least Feb 12, 2020); Jiya Acquisition Corp (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Geron Corporation (EVP, R&D, Chief Med Officer · Apr 27, 2009 – May 3, 2013 · Past) | SVP of New Projects · May 13, 2013 – Feb 18, 2014 · Past |
| Mohammad Hirmand Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Mar 27, 2023); Turning Point Therapeutics Inc (EVP and Chief Medical Officer · Dec 2, 2019 – Aug 17, 2022 · Past) | Interim Chief Medical Officer · Sep 29, 2015 – Sep 28, 2016 · Past |
Log in to ask 6ix AI your own questions about Medivation Inc.